Abstract
Objectives: Approximately 15% of breast cancers show equivocal human epidermal growth factor receptor 2 (HER2) results on HER2 immunohistochemistry (I......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
